CASI

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS

Retrieved on: 
Monday, April 8, 2024
CASI, Therapy, Cayman, CASI Pharmaceuticals, Form 6-K

BEIJING, April 8, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported that it has furnished a current report on Form 6-K to disclose material development relating to its dispute with Juventas.

Key Points: 
  • BEIJING, April 8, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported that it has furnished a current report on Form 6-K to disclose material development relating to its dispute with Juventas.
  • For details, please visit below link:

Revolutionizing Sustainable Finance: CASI's Inaugural In-Person Event Spurs Collaboration and Capacity Building in Sao Paulo

Retrieved on: 
Sunday, April 7, 2024
ICS, Climate change, Organization, SAO, CASI, Ma Jun, International financial institutions, Biodiversity, COP28, Ecosystem, Ministry, Developed country, UN, Renewable energy

SAO PAULO, April 7, 2024 /PRNewswire/ -- The Capacity-building Alliance of Sustainable Investment (CASI) held its inaugural in-person event in Sao Paulo, Brazil, from April 3-5, 2024.

Key Points: 
  • SAO PAULO, April 7, 2024 /PRNewswire/ -- The Capacity-building Alliance of Sustainable Investment (CASI) held its inaugural in-person event in Sao Paulo, Brazil, from April 3-5, 2024.
  • Launched amidst the momentum of COP28, CASI is dedicated to amplifying capacity for sustainable finance and investment across emerging markets and developing countries (EMDEs).
  • Bolstered by a global membership of over 50 organizations and continuously expanding, CASI galvanizes collective efforts from diverse stakeholders worldwide.
  • The event facilitated dynamic discussions and knowledge exchange among stakeholders from Brazil and Latin America's sustainable investment ecosystem.

CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS

Retrieved on: 
Thursday, March 28, 2024
Agreement, Transplant, CASI Pharmaceuticals, CASI, Patient, Travel, PTCL, Immunoglobulin G, CMC, Depreciation, Bone marrow, Therapy, VCP, Marketing, Research, Cleave, Pralatrexate, MCL, Rituximab, AML, Pembrolizumab, Trial of the century, Myelodysplastic syndrome, Melphalan, MDS, Clinical trial, Follicular lymphoma, Republic, Multiple myeloma, Acute myeloid leukemia, Annual report, National Medical Products Administration, Haematopoietic system, FDA, Cayman, CD19, NMPA, COVID-19, CTA, HKIAC, NHL, Non-Hodgkin lymphoma, MICL, Pharmaceutical industry

BEIJING, March 28, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported business and financial results for the year ended December 31, 2023, and provided an update on key highlights for 2023.

Key Points: 
  • BEIJING, March 28, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported business and financial results for the year ended December 31, 2023, and provided an update on key highlights for 2023.
  • CASI reported fourth quarter 2023 revenue of $6.9 million for EVOMELA®, 33% lower than the same period in 2022.
  • 2023 marks a major milestone for CASI and our partner Juventas; Inaticabtagene Autoleucel (CNCT-19 CAR-T cell therapy) was approved by National Medical Products Administration (NMPA) in November 2023.
  • As of December 31, 2023, CASI had cash, cash equivalents and short term investment of $29.1 million compared to $48.6 million as of December 31, 2022.

Hy-Tek Intralogistics and CASI Announce Partnership

Retrieved on: 
Tuesday, March 19, 2024
Partnership, Automation, CASI, Duo, New product development

COLUMBUS, OH., March 19, 2024 /PRNewswire/ -- Hy-Tek Intralogistics, a premier integrator of full-service automation technology for the supply chain, has partnered with CASI, a leading provider of turnkey automation systems.

Key Points: 
  • COLUMBUS, OH., March 19, 2024 /PRNewswire/ -- Hy-Tek Intralogistics, a premier integrator of full-service automation technology for the supply chain, has partnered with CASI, a leading provider of turnkey automation systems.
  • "We are excited to start our partnership with CASI and be able to offer their solutions to our customers," said Zac Boehm, Chief Automation Officer at Hy-Tek Intralogistics.
  • "By formalizing our partnership, it allows Hy-Tek to add to its existing solutions with a technology that focuses on providing a balance of high-automation with human operations, to help improve accuracy and efficiency."
  • "This partnership will help customers increase efficiencies, leverage automation and reduce cost of warehouse solutions."

Associa Community Association Services of Indiana Hosts Meet & Match Event for Vendors and Community Association Managers

Retrieved on: 
Friday, February 16, 2024
CMCA, Bravely Default II, Branch, CASI, Business development

DALLAS, Feb. 16, 2024 (GLOBE NEWSWIRE) -- The Associa Community Association Services of Indiana hosted a Vendor-Community Association Manager “Meet and Match” event on February 07, 2024, at their Branch offices in Carmel, Indiana.

Key Points: 
  • DALLAS, Feb. 16, 2024 (GLOBE NEWSWIRE) -- The Associa Community Association Services of Indiana hosted a Vendor-Community Association Manager “Meet and Match” event on February 07, 2024, at their Branch offices in Carmel, Indiana.
  • The goal of the one-day event was to enhance professional collaboration and preparedness for maintenance needs in CASI-managed communities.
  • The Valentine’s Day themed event kicked off by welcoming industry partners, who were invited to meet Associa managers one-on-one and learn about their communities’ needs.
  • If you would like more information about Community Association Services of Indiana, visit www.cas-indiana.com .

Community Association Services Of Indiana To Host Free Legal Consultation Webinar For Managed Community Board Members

Retrieved on: 
Tuesday, December 5, 2023
CASI

CARMEL, Ind., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Associa Community Association Services of Indiana (CASI) invites you to a free legal consultation webinar for managed communities.

Key Points: 
  • CARMEL, Ind., Dec. 05, 2023 (GLOBE NEWSWIRE) -- Associa Community Association Services of Indiana (CASI) invites you to a free legal consultation webinar for managed communities.
  • Current and potential clients are welcome to attend and discuss a range of issues related to community association living, legal guidelines and best legal practices in Indiana managed communities.
  • The seminar is a part of CASI’s ongoing “7 at 7” Board Education series, designed to help board members to navigate through the essential aspects of community management year-round.

Community Association Services Of Indiana Hosts Annual Fundraiser To Support Associa Cares Charitable Organization

Retrieved on: 
Wednesday, November 15, 2023
Bravely Default II, CASI, Warren Park, Indiana

CARMEL, Ind., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Associa Community Association Services of Indiana (CASI) a leading provider of community management services throughout Indianapolis and surrounding counties, recently hosted its annual Client Appreciation and Vendor Networking Event.

Key Points: 
  • CARMEL, Ind., Nov. 15, 2023 (GLOBE NEWSWIRE) -- Associa Community Association Services of Indiana (CASI) a leading provider of community management services throughout Indianapolis and surrounding counties, recently hosted its annual Client Appreciation and Vendor Networking Event.
  • One hundred percent of the donations raised benefitted Associa’s affiliate charity, Associa Cares , which helps families and communities in need as a result of natural and man-made disasters.
  • A mix of vendor partners, client board members, and Associa employees took part in the event.
  • “Thanks to the tremendous generosity of our vendor partners and event sponsors we were able to stage another successful event in support of Associa Cares,” said Community Association Services of Indiana Branch President Jennifer Freemen.

Capacity-building Alliance of Sustainable Investment (CASI) Launched at COP28

Retrieved on: 
Tuesday, December 5, 2023
Disclosure, Policy, CASI, HSBC, COP28, Chairperson, ISSB, University, CFA Institute, Silk Road Fund, Growth, Capacity building, HKMA, Standard Chartered, Non-governmental organization, Renewable energy, Tourism, Hong Kong

DUBAI, UAE, Dec. 5, 2023 /PRNewswire/ -- Ma Jun, President of the Beijing-based Institute of Finance and Sustainability (IFS) and former Co-Chair of the G20 Sustainable Finance Working Group (SFWG), together with representatives from six other founding members, launched the Capacity-building Alliance of Sustainable Investment (CASI) today at COP28.

Key Points: 
  • DUBAI, UAE, Dec. 5, 2023 /PRNewswire/ -- Ma Jun, President of the Beijing-based Institute of Finance and Sustainability (IFS) and former Co-Chair of the G20 Sustainable Finance Working Group (SFWG), together with representatives from six other founding members, launched the Capacity-building Alliance of Sustainable Investment (CASI) today at COP28.
  • "The demand for sustainable investment is huge in EMDEs, but most of these economies are yet to put in place the key elements of a green financial system.
  • Eddie Yue, Chief Executive of HKMA, said "EMDEs are facing steep pathways to meet their sustainable development goals, requiring substantial investment.
  • Bill Winters, CEO of Standard Chartered Bank, said "CASI demonstrates the value of constructive partnerships to accelerate sustainable investment.

Capacity-building Alliance of Sustainable Investment (CASI) Launched at COP28

Retrieved on: 
Tuesday, December 5, 2023
Disclosure, Policy, CASI, HSBC, COP28, Chairperson, ISSB, University, CFA Institute, Silk Road Fund, Growth, Capacity building, HKMA, Standard Chartered, Non-governmental organization, Renewable energy, Tourism, Hong Kong

DUBAI, UAE, Dec. 5, 2023 /PRNewswire/ -- Ma Jun, President of the Beijing-based Institute of Finance and Sustainability (IFS) and former Co-Chair of the G20 Sustainable Finance Working Group (SFWG), together with representatives from six other founding members, launched the Capacity-building Alliance of Sustainable Investment (CASI) today at COP28.

Key Points: 
  • DUBAI, UAE, Dec. 5, 2023 /PRNewswire/ -- Ma Jun, President of the Beijing-based Institute of Finance and Sustainability (IFS) and former Co-Chair of the G20 Sustainable Finance Working Group (SFWG), together with representatives from six other founding members, launched the Capacity-building Alliance of Sustainable Investment (CASI) today at COP28.
  • "The demand for sustainable investment is huge in EMDEs, but most of these economies are yet to put in place the key elements of a green financial system.
  • Eddie Yue, Chief Executive of HKMA, said "EMDEs are facing steep pathways to meet their sustainable development goals, requiring substantial investment.
  • Bill Winters, CEO of Standard Chartered Bank, said "CASI demonstrates the value of constructive partnerships to accelerate sustainable investment.

CASI PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2023 BUSINESS AND FINANCIAL UPDATES

Retrieved on: 
Tuesday, November 14, 2023
Acquisition, Research, National Medical Products Administration, CASI, Investment, CASI Pharmaceuticals, NMPA, Cell, Marketing, Therapy, B-ALL, Acute lymphoblastic leukemia, Melphalan, Pharmaceutical industry, Cryptocurrency, Juventas

BEIJING, Nov. 14, 2023 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported business and financial results for the third quarter ended September 30, 2023.

Key Points: 
  • BEIJING, Nov. 14, 2023 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company focused on developing and commercializing innovative therapeutics and pharmaceutical products, today reported business and financial results for the third quarter ended September 30, 2023.
  • He further added, "Our sales revenue for the third quarter of 2023 was $8.8 million, representing a decrease of 13.5% compared to the same period last year and a decrease of 10% from the second quarter of 2023.
  • Revenue was $8.8 million for the three months ended September 30, 2023, compared to $10.2 million for the three months ended September 30, 2022.
  • As of September 30, 2023, CASI had cash, cash equivalents and short-term investments of $34.2 million.